About UTC Investment
UTC Investment is a private equity firm founded in 1988. It is primarily based in Seoul, South Korea. As of Jan 2026, UTC Investment has a portfolio of 140 companies, comprising 139 funding rounds and 2 acquisitions. The firm primarily invests in companies based in South Korea and United States. Its portfolio is spread across a wide range of sectors from Life Sciences to Enterprise Applications. Its latest investment was a $***** Series C round in WashSwat on Nov 28, 2024 which also saw participation from We Ventures, Strong Ventures and other investors.
Overall UTC Investment portfolio has seen 1 unicorn, 20 IPOs and 7 acquisitions including key companies like Kurly, SemiFive and Rznomics. A lot of funds co-invest with UTC Investment, with names like Korea Investment Holdings sharing a substantial percentage of its portfolio.
UTC Investment has a team of 7 people, including 2 partners.
Key Metrics
UTC Investment's Portfolio
UTC Investment has a portfolio of 140 companies. They have invested in a total of 139 companies. Their most recent investment was in WashSwat (Series C round) on Nov 28, 2024. Here are the most recent investments by UTC Investment:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Nov 28, 2024 | Series C | 4869 | and 3 others | |
Oct 02, 2024 | Series B | 8114 | ||
Aug 06, 2024 | Series A | 5057 | ||
Feb 07, 2024 | Series B | 5889 |
UTC Investment has acquired 2 companies. Their most recent acquisition was of VNPT EPAY on Nov 18, 2016. Here are the most recent acquisitions by UTC Investment:
Acquisition Date | Company | Short Description | Total Funding | Founded Year |
|---|---|---|---|---|
Nov 18, 2016 | Payment & financial solutions for businesses | - | 2008 | |
- | Prepaid card payment solution for consumers | - | 2000 |
Here is the portfolio snapshot of UTC Investment:
Investments by Year
The maximum number of investments were made in 2020
Portfolio by Location
Companies are primarily in South Korea and United States
Portfolio by Sector
Companies are primarily in Life Sciences
Team profile of UTC Investment
UTC Investment has a team of 7 members including 2 Partners located in South Korea. UTC Investment's team does not sit on the board of any company as of now.Co-investors of UTC Investment
Over the past 38 years, 66 investors have co-invested in UTC Investment's portfolio companies.
- Top Co-investors of UTC Investment: 66 investors entered a company along with UTC Investment. These include investors like Korea Investment Holdings (5 companies).
UTC Investment News
•
Washiswat, operator of 'Laundry Task Force', attracts 7 billion won in Series C investment
Wowtale•Nov 27, 2024•WashSwat, We Ventures, UTC Investment, Strong Ventures and 2 others
•
Medical AI 'Monitor Corporation' Attracts 7 Billion Won Series B InvestmentWowtale•Oct 02, 2024•UTC Investment, HB Investments
•
Digital Healthcare 'Allround Doctors' Attracts 7 Billion Won Series A InvestmentWowtale•Aug 06, 2024•Allround Doctors, Aon Investment, UTC Investment, FuturePlay and 4 others
•
Total fulfillment ‘Bold Nine’ attracts Series B investment “25-year IPO goal”Wowtale•Feb 07, 2024•BOLD9, POSCO Capital, Smile Gate Investment, UTC Investment and 1 other
•
Gexval Co., Ltd., which researches and develops drugs for intractable and rare diseases, raises a total of approximately 450 million yen in C round funding.startuplog.com•Dec 04, 2023•GEXVal, Axil Capital, UTC Investment, Mitsubishi UFJ Capital and 1 other
•
Zymedi, Series A Bridge 16 billion “KARS New Drug US Phase 1”BioSpectator•May 30, 2023•Zymedi, UTC Investment, Industrial Bank of Korea, Korea Venture Investment Corp and 3 others
•
Avelos Therapeutics Announces $8 Millon Series A Funding RoundPR Newswire•Aug 22, 2022•Mirae Asset Capital Markets, Avelos Therapeutics, Somers Investment Partners, QUAD and 5 others
•
USD 30 million Series B Investment Further Accelerates the Development of SLC-3010Selecxine•Mar 22, 2022•Selecxine, Stonebridge Ventures, STIC Ventures, Medytox and 7 others
•
Seattle stem cell startup lands $10M to speed development of its drug discovery platformsThe Business Journals•Dec 30, 2021•Curi Bio, Sumitomo Mitsui DS Asset Management, Dynamk Capital, UTC Investment and 1 other
•
CAR-T therapy developer Ticaros raises $21mn in series CPulse•Aug 30, 2021•Tikaros, Shinhan Venture Investment, UTC Investment, Woori Investment Bank and 1 other
